Capital One Financial Weighs in on EyePoint Pharmaceuticals, Inc.’s Q1 2024 Earnings (NASDAQ:EYPT)
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Capital One Financial raised their Q1 2024 earnings per share (EPS) estimates for EyePoint Pharmaceuticals in a report issued on Monday, May 6th. Capital One Financial analyst T. Chiang now expects that the company will post earnings of ($0.32) per share for the quarter, up from their […]
More Stories
Reviewing FFBW (NASDAQ:FFBW) & Carver Bancorp (NASDAQ:CARV)
Profitability This table compares FFBW and Carver Bancorp’s net margins, return on equity and return on assets. Net Margins Return...
Valuence Merger Corp. I (VMCA) & Its Rivals Financial Review
Volatility and Risk Valuence Merger Corp. I has a beta of 0.01, indicating that its stock price is 99% less...
Russia Will Help China Advance Submarine Technology, US Indo-Pacific Commander Says
By Frank Fang In return for China’s support during its war on Ukraine, Russia will likely assist Beijing to advance...
Financial Contrast: Carnival Co. & (NYSE:CUK) versus Viking (NYSE:VIK)
Viking (NYSE:VIK – Get Free Report) and Carnival Co. & (NYSE:CUK – Get Free Report) are both transportation companies, but...
Centaurus Financial Inc. Lowers Stock Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Centaurus Financial Inc. cut its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 2.5%...
PepsiCo, Inc. (NASDAQ:PEP) Shares Purchased by Summit Trail Advisors LLC
Summit Trail Advisors LLC increased its position in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 18.3% during the...